Suloctidil

Suloctidil was a sulfur-containing aminoalcohol that was brought to market in the early 1970s as a vasodilator by Continental Pharma, a Belgian company.^{[1]: 118–121 [2][3]}

Suloctidil

Clinical data
ATC code	C04AX19 (WHO)
Identifiers
IUPAC name 1-[4-(isopropylthio)phenyl]-2-(octylamino)propan-1-ol
CAS Number	54767-75-8 Y
PubChem CID	5354
UNII	XV1N1XY17K
ChEBI	CHEBI:233445
ChEMBL	ChEMBL588119
CompTox Dashboard (EPA)	DTXSID701017974 DTXSID4045638, DTXSID701017974
ECHA InfoCard	100.053.920
Chemical and physical data
Formula	C20H35NOS
Molar mass	337.57 g·mol−1
(verify)

Continental was bought by Monsanto in 1984, primarily on the promise of sales of suloctidil, which was approved in Europe at the time, but not in the US.^[4] However, in 1985 Monsanto halted development and withdrew the drug worldwide following reports of liver toxicity.^[5]: 251